Verastem (VSTM) Competitors $5.35 +0.08 (+1.52%) Closing price 04:00 PM EasternExtended Trading$5.34 -0.01 (-0.28%) As of 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VSTM vs. OPK, GERN, ZBIO, RGLS, LXRX, MYGN, EBS, RIGL, XOMA, and VNDAShould you be buying Verastem stock or one of its competitors? The main competitors of Verastem include OPKO Health (OPK), Geron (GERN), Zenas BioPharma (ZBIO), Regulus Therapeutics (RGLS), Lexicon Pharmaceuticals (LXRX), Myriad Genetics (MYGN), Emergent Biosolutions (EBS), Rigel Pharmaceuticals (RIGL), XOMA Royalty (XOMA), and Vanda Pharmaceuticals (VNDA). These companies are all part of the "biotechnology" industry. Verastem vs. Its Competitors OPKO Health Geron Zenas BioPharma Regulus Therapeutics Lexicon Pharmaceuticals Myriad Genetics Emergent Biosolutions Rigel Pharmaceuticals XOMA Royalty Vanda Pharmaceuticals OPKO Health (NASDAQ:OPK) and Verastem (NASDAQ:VSTM) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation. Do analysts rate OPK or VSTM? OPKO Health currently has a consensus price target of $2.75, suggesting a potential upside of 92.31%. Verastem has a consensus price target of $13.38, suggesting a potential upside of 150.00%. Given Verastem's higher probable upside, analysts clearly believe Verastem is more favorable than OPKO Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OPKO Health 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Verastem 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation and earnings, OPK or VSTM? OPKO Health has higher revenue and earnings than Verastem. OPKO Health is trading at a lower price-to-earnings ratio than Verastem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOPKO Health$713.10M1.59-$53.22M-$0.07-20.43Verastem$10K29,398.25-$130.64M-$3.20-1.67 Which has more volatility and risk, OPK or VSTM? OPKO Health has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, Verastem has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Do insiders & institutionals hold more shares of OPK or VSTM? 64.6% of OPKO Health shares are held by institutional investors. Comparatively, 88.4% of Verastem shares are held by institutional investors. 49.7% of OPKO Health shares are held by company insiders. Comparatively, 2.1% of Verastem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media favor OPK or VSTM? In the previous week, Verastem had 3 more articles in the media than OPKO Health. MarketBeat recorded 3 mentions for Verastem and 0 mentions for OPKO Health. OPKO Health's average media sentiment score of 0.00 beat Verastem's score of -0.10 indicating that OPKO Health is being referred to more favorably in the media. Company Overall Sentiment OPKO Health Neutral Verastem Neutral Is OPK or VSTM more profitable? Verastem has a net margin of 0.00% compared to OPKO Health's net margin of -5.66%. OPKO Health's return on equity of -2.85% beat Verastem's return on equity.Company Net Margins Return on Equity Return on Assets OPKO Health-5.66% -2.85% -1.82% Verastem N/A -2,003.62%-127.97% SummaryOPKO Health beats Verastem on 9 of the 16 factors compared between the two stocks. Get Verastem News Delivered to You Automatically Sign up to receive the latest news and ratings for VSTM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VSTM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VSTM vs. The Competition Export to ExcelMetricVerastemMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$293.98M$3.04B$5.67B$9.46BDividend YieldN/A2.49%4.01%4.00%P/E Ratio-1.6721.3928.0920.14Price / Sales29,398.25265.12416.0798.39Price / CashN/A41.6635.9658.29Price / Book-8.238.208.565.81Net Income-$130.64M-$55.10M$3.24B$258.35M7 Day Performance1.90%7.71%4.59%3.95%1 Month Performance15.80%21.81%12.90%14.86%1 Year Performance49.03%6.52%35.37%19.27% Verastem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VSTMVerastem3.3028 of 5 stars$5.35+1.5%$13.38+150.0%+54.1%$293.98M$10K-1.6750High Trading VolumeOPKOPKO Health3.6288 of 5 stars$1.40+3.7%$2.75+96.4%-5.5%$1.07B$689.41M-20.002,997GERNGeron3.4576 of 5 stars$1.23-0.8%$4.61+274.9%-72.6%$783.41M$116.29M-5.8670Analyst RevisionZBIOZenas BioPharma1.121 of 5 stars$14.29+4.1%$36.67+156.6%N/A$597.75M$5M-4.03N/ARGLSRegulus Therapeutics1.7288 of 5 stars$8.16flat$8.50+4.2%N/A$564.92MN/A-11.1830LXRXLexicon Pharmaceuticals2.54 of 5 stars$1.23flat$3.67+198.1%-43.1%$444.63M$31.08M-2.41140Upcoming EarningsMYGNMyriad Genetics4.5098 of 5 stars$4.45-0.4%$14.38+223.2%-83.5%$410.20M$837.60M-3.972,700Gap UpEBSEmergent Biosolutions3.9303 of 5 stars$6.93+0.0%$14.33+106.8%-37.6%$376.14M$1.04B0.002,420RIGLRigel Pharmaceuticals3.233 of 5 stars$19.59+4.2%$36.40+85.8%+98.4%$350.07M$179.28M9.46160News CoveragePositive NewsXOMAXOMA Royalty3.8372 of 5 stars$25.48-0.7%$69.50+172.8%-11.0%$305.00M$28.49M-22.1610VNDAVanda Pharmaceuticals4.6204 of 5 stars$4.66-2.5%$16.50+254.1%-25.7%$274.61M$198.77M-6.21290News CoverageUpcoming Earnings Related Companies and Tools Related Companies OPKO Health Alternatives Geron Alternatives Zenas BioPharma Alternatives Regulus Therapeutics Alternatives Lexicon Pharmaceuticals Alternatives Myriad Genetics Alternatives Emergent Biosolutions Alternatives Rigel Pharmaceuticals Alternatives XOMA Royalty Alternatives Vanda Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VSTM) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verastem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verastem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VSTM Stock Alerts